MERCK ACCESS AND SUPPORT

Before prescribing ZEPATIER, please read the accompanying Prescribing Information, including the Boxed Warning about the risk of hepatitis B virus (HBV) reactivation in patients with HBV coinfection. The Patient Information also is available.
 
 
WELCOME TO
MERCK ACCESS
AND SUPPORT
 
ARE YOU A US HEALTH CARE PROFESSIONAL?
Yes
No

 
MERCK ACCESS PROGRAM
If you choose not to use a network speciality pharmacy,
The Merck Access Program can help answer your questions about
  • Insurance coverage for patients
  • Benefit investigations and prior authorizations
  • Appeals
  • Potential financial assistance options for eligible patients
  • Forwarding of prescription to pharmacy
Model
GETTING STARTED IS SIMPLE!
Contact The Merck Access Program Mon–Fri, 8 AM to 8 PM (ET)
866-251-6013
 
Download The Merck Access Program Enrollment Form for ZEPATIER® (elbasvir and grazoprevir)